Known targets — ChEMBL curated mechanism
ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A known ✓ | P08908 | 1/20 | 0.44 |
| ▸ | HTR2C | P28335 | 6/20 | 0.61 |
| ▸ | DRD1 | P21728 | 3/20 | 0.52 |
| ▸ | PTPRCAP | Q14761 | 2/20 | 0.52 |
| ▸ | DRD2 | P14416 | 4/20 | 0.51 |
| ▸ | HTR2A | P28223 | 1/20 | 0.51 |
| ▸ | HTR2B | P41595 | 1/20 | 0.51 |
| ▸ | DRD3 | P35462 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1345825 | 0.99 | HTR2C (0.62) | HTR2CDRD1PTPRCAPDRD2HTR2A | |
| SCHEMBL3160390 | 0.89 | HTR2C (0.65) | HTR2CDRD1PTPRCAPDRD2HTR2A | |
| SCHEMBL3178138 | 0.81 | HTR2C (0.58) | HTR2CDRD1PTPRCAPDRD2HTR2A | |
| SCHEMBL6237859 | 0.79 | HTR2C (0.70) | HTR2CDRD1PTPRCAPDRD2HTR2A | |
| SCHEMBL3174699 | 0.77 | HTR2C (0.68) | HTR2CDRD1PTPRCAPDRD2HTR2A | |
| Bromide SCHEMBL7111710 | 0.74 | HTR2C (0.57) | HTR2CDRD1PTPRCAPDRD2HTR2A | |
| SCHEMBL3176273 | 0.74 | HTR2C (0.63) | HTR2CDRD1PTPRCAPDRD2HTR2A | |
| SCHEMBL276490 | 0.74 | DRD2 (0.60) | HTR2CDRD1DRD2HTR2ADRD3 | |
| SCHEMBL14782159 | 0.73 | HTR2C (0.58) | HTR2CDRD1PTPRCAPDRD2HTR2A | |
| SCHEMBL1345733 | 0.72 | HTR1A (0.63) | HTR2CDRD1PTPRCAPDRD2HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1397134-A2 | COMBINATION OF A DOPAMINE D2-RECEPTOR AGONIST AND TIOTROPIUM OR A DERIVATIVE THEROF FOR TREATING OBSTRUCTIVE AIRWAYS | Boehringer Ingelheim Pharma GmbH & Co.KG (DE) | 2004-03-17 | — | — | EP | disclosed |
| WO-2002096422-A2 | COMBINATION OF A DOPAMINE D2-RECEPTOR AGONIST AND TIOTROPIUM OR A DERIVATIVE THEREOF FOR TREATING OBSTRUCTIVE AIRWAYS | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2002-12-05 | — | — | WO | disclosed |